FDA Approves Remdesivir, the First COVID-19 Treatment
Linda Bernstein, Pharm.D.
PeerReopening Practices in Light of COVID-19
Investigating the Circulation of Counterfeit COVID-19 Medications
Charles Turck, PharmD, BCPS, BCCCP
PeerAdvocacy Efforts During the COVID-19 Pandemic
Perspectives on Responding Administratively to a Pandemic: Notes from a Children’s Hospital
Artificial Intelligence’s Role in Combating the Antibiotic Resistance Crisis
The DEA’s Adjustment to Schedule II Rules Amid COVID-19
Linda Bernstein, Pharm.D.
PeerLinda Bernstein, Pharm.D.
PeerCoagulopathy in COVID-19: Cause or Effect?
Linda Bernstein, Pharm.D.
PeerOff-Label Medicines in Fighting COVID-19 & Through the Years
John Russell, MD
PeerLinda Bernstein, Pharm.D.
PeerDrug Shortages During the COVID-19 Pandemic
Linda Bernstein, Pharm.D.
PeerLinda Bernstein, Pharm.D.
PeerLinda Bernstein, Pharm.D.
PeerLinda Bernstein, Pharm.D.
Peer